5/7/19: The Doctors Company And UCSF Launch A Novel Collaboration To Advance Patient Safety In The Digital Era

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

The Doctors Company and UCSF have launched a new partnership at the intersection of digital medicine and patient safety. The Doctors Company’s commitment to advancing the practice of good medicine will be expanded through a $1 million collaboration that will enable leading UCSF researchers in evidence-based patient safety practices, safety and information technology–related policy, and artificial intelligence (AI) to pursue cutting-edge questions.

Widespread digitization of the healthcare system over the past decade—including electronic health records (EHRs), apps, and sensors—offers new ways to study and address traditional patient safety challenges such as diagnostic and medication errors. There also are new challenges that stem directly from these emerging digital capabilities, including how to integrate AI tools into front-line care, mitigate alert fatigue, share data with patients, preserve the physician-patient relationship with increasing use of technology in the exam room and asynchronous communication tools, avoid physician burnout related to suboptimal EHR usability and performance, and ensure cybersecurity.

The Doctors Company–UCSF collaboration will maximize the strengths of both organizations to make substantive advances in patient safety and digital health through novel research and engagement, with the goal of safer care. According to Richard E. Anderson, MD, FACP, chairman and chief executive officer of The Doctors Company, “We are proud to partner with a world-class institution like UCSF in a mission-based collaboration that has the power to improve medical outcomes in the transformative sphere of digital healthcare.”

The UCSF team is led by two accomplished researchers—Julia Adler-Milstein, PhD, associate professor of medicine, and Urmimala Sarkar, MD, associate professor of medicine, who bring complementary expertise to the partnership. According to Dr. Adler-Milstein, “The primary goal of the partnership is to discover and disseminate new insights into risk mitigation strategies and patient safety by connecting top-tier UCSF researchers and unique resources and expertise from The Doctors Company. It is a rare and exciting opportunity to have two such organizations come together to jointly advance such an important area.”

Dr. Sarkar is specifically excited about “the valuable opportunity to learn more about errors in diagnosis for outpatient physicians across a range of practice settings, and to find creative ways to improve medical practice.” Dr. Robert Wachter, chair of UCSF’s Department of Medicine and a member of The Doctors Company’s Board of Governors, has championed this collaboration. “The Doctors Company insures 82,000 physicians in the U.S. and has a rare window into the causes of medical errors and strategies to mitigate them. By leveraging UCSF’s world-class research community, we believe that we can develop new insights into safety hazards and strategies to keep patients safe.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.